libmeldy
orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - andre narkotika stoffer - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still have the ability to walk independently and before the onset of cognitive decline.
asasantine retard 200 + 25 mg depotkapsler, hårde
orifarm a/s - acetylsalicylsyre, dipyridamol - depotkapsler, hårde - 200 + 25 mg
gemadol retard 50 mg depotkapsler
viatris aps - tramadolhydrochlorid - depotkapsler - 50 mg
gemadol retard 50 mg depotkapsler
2care4 aps - tramadolhydrochlorid - depotkapsler - 50 mg
medikinet retard 20 mg kapsler med modificeret udløsning, hårde
orifarm a/s - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 20 mg
medikinet retard 30 mg kapsler med modificeret udløsning, hårde
orifarm a/s - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 30 mg
medikinet retard 40 mg kapsler med modificeret udløsning, hårde
orifarm a/s - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 40 mg
medikinet retard 50 mg kapsler med modificeret udl?sning, h?rde
orifarm a/s - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 50 mg
medikinet retard 60 mg kapsler med modificeret udl?sning, h?rde
orifarm a/s - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 60 mg
asasantin retard 200 + 25 mg depotkapsler, hårde
boehringer ingelheim int. gmbh - acetylsalicylsyre, dipyridamol - depotkapsler, hårde - 200 + 25 mg